Wetherby drug developer Avacta secures quality certification

Drug developer Avacta has achieved ISO 13485 certification for the quality management system for the manufacture and distribution of Affimer reagents for use in lateral flow, ELISA and immunodiagnostic in-vitro diagnostic devices.
By Ismail Mulla
Published 14th Jul 2021, 08:28 BST
Updated 14th Jul 2021, 08:30 BST
Dr Alastair Smith, CEO of Avacta , said: “We are delighted that Avacta’s diagnostics division has achieved ISO 13485 certification."Dr Alastair Smith, CEO of Avacta , said: “We are delighted that Avacta’s diagnostics division has achieved ISO 13485 certification."
Dr Alastair Smith, CEO of Avacta , said: “We are delighted that Avacta’s diagnostics division has achieved ISO 13485 certification."

The Wetherby-based firm, which has created rapid delivery Covid-19 tests, says it is "delighted" with the certification.

The ISO 13485 standard defines the comprehensive requirements for quality management for a developer and legal manufacturer of diagnostic products and medical devices.

Hide Ad
Hide Ad

The certification, which provides a practical foundation for Avacta to address the regulatory requirements and ensure the safety and quality of its products, follows after having successfully passed the audit by the Avacta’s notified body of the company’s quality management system in April 2021.

ISO 13485 certification means that the CE mark for the AffiDX SARS-CoV-2 antigen lateral flow test can be transferred to Avacta from its partner Mologic and the Wetherby-based will be legal manufacturer of all future in-vitro diagnostic products.

Dr Alastair Smith, CEO of Avacta , said: “We are delighted that Avacta’s diagnostics division has achieved ISO 13485 certification. The team have delivered excellent systems, processes and practices that now make up our quality framework, supporting the future growth and commercial success of the company.

“ISO 13485 certification is recognised globally by our partners, customers and regulatory bodies alike as the medical device industry benchmark for quality. This certification marks a major milestone for Avacta and underpins the product development strategy for the future of our diagnostics division.”

---

---

Support The Yorkshire Post and become a subscriber today.

Hide Ad
Hide Ad

Your subscription will help us to continue to bring quality news to the people of Yorkshire. In return, you'll see fewer ads on site, get free access to our app and receive exclusive members-only offers.

So, please - if you can - pay for our work. Just £5 per month is the starting point. If you think that which we are trying to achieve is worth more, you can pay us what you think we are worth. By doing so, you will be investing in something that is becoming increasingly rare. Independent journalism that cares less about right and left and more about right and wrong. Journalism you can trust.

Thank you

James Mitchinson

Related topics:Wetherby